Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04080-6
Abstract: In preclinical models of biliary tract cancer, NUC-1031 showed less potency than gemcitabine, no correlation with potential biomarkers and only moderate additive interaction in combination with cisplatin. These findings should prompt further careful pharmacological and…
read more here.
Keywords:
biliary tract;
1031 biliary;
tract cancer;
nuc 1031 ... See more keywords